EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents

Arendrup, Maiken; Meletiadis, Joseph; Mouton, Johan; Guinea, Jesús; Cuenca-Estrella, Manuel; Lagrou, Katrien; Howard, Susan

doi:10.1016/j.cmi.2016.01.017

dc.contributor.author	Arendrup, Maiken
dc.contributor.author	Meletiadis, Joseph
dc.contributor.author	Mouton, Johan
dc.contributor.author	Guinea, Jesús
dc.contributor.author	Cuenca-Estrella, Manuel
dc.contributor.author	Lagrou, Katrien
dc.contributor.author	Howard, Susan
dc.date.accessioned	2024-02-06T11:51:29Z
dc.date.available	2024-02-06T11:51:29Z
dc.date.issued	2016-06-01
dc.identifier.issn	1198-743X
dc.identifier.other	https://www.clinicalmicrobiologyandinfection.com/	es
dc.identifier.uri	http://hdl.handle.net/20.500.12020/1253
dc.description.abstract	The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) has determined breakpoints for isavuconazole and Aspergillus and for itraconazole and Candida spp., released a new document summarizing existing and new minimum inhibitory concentration ranges for quality control strains and revised the method documents for yeast and mould susceptibility testing. This technical note is based on the EUCAST isavuconazole and itraconazole rationale documents, version 1.0 of the routine and extended internal quality control for antifungal susceptibility testing as recommended by EUCAST, and the E.Def 7.3, E.Def 9.2 and E.Def 9.3 method documents (http://www. eucast.org).	es
dc.language.iso	en	es
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.title	EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents	es
dc.type	article	es
dc.identifier.doi	10.1016/j.cmi.2016.01.017
dc.issue.number	6	es
dc.journal.title	Clinical Microbiology and Infection	es
dc.page.initial	571.e1	es
dc.page.final	571.e4	es
dc.rights.accessRights	openAccess	es
dc.subject.area	Ciencias Biomédicas	es
dc.subject.keyword	Antifungal susceptibility testing	es
dc.subject.keyword	Breakpoints	es
dc.subject.keyword	Isavuconazole	es
dc.subject.keyword	Itraconazole	es
dc.subject.keyword	QC MICs	es
dc.subject.keyword	Breakpoints
dc.subject.keyword	Isavuconazole
dc.subject.keyword	Itraconazole
dc.subject.keyword	QC MIC ranges
dc.subject.unesco	3201.03 Microbiología Clínica	es
dc.volume.number	22	es

Files in this item

File/s	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Investigación

Show simple item record

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional